What You Should Know: – Health insurer Highmark expands access to FDA-cleared digital therapeutic Freespira proven to reduce the symptoms of panic disorder and PTSD for members in Pennsylvania, Delaware and Virginia. – The announcement follows a pilot study finding that nearly 9 out of 10 patients using the solution were symptom-free after treatment. Highmark Inc., the fourth-largest Blue Cross Blue Shield-affiliated organization announced it is expanding access to Freespira’s FDA-cleared digital therapeutic to significantly reduce or eliminate symptoms of panic attacks, panic disorder and post-traumatic stress disorder (PTSD) to its members throughout Pennsylvania, Delaware and West Virginia. Freespira-Highmark Pilot Results Highmark originally piloted Freespira in 2016 as part of its VITAL Innovation program to help members suffering from panic disorder obtain relief with a new treatment option that not only reduced or eliminated panic attacks but also led to decreased utilization of medical services and decreased medical costs. The pilot also found the digital therapeutic saved 65% on emergency department costs as fewer people showed up at the ER complaining of anxiety symptoms.